Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Are Investors Being Too Paranoid About Pfizer Stock?
08:30am, Thursday, 13'th Feb 2025
Investing in a top healthcare company whose share price has been tanking in recent years could present a huge opportunity for investors, especially when that company has been bolstering its growth pro
3 Brand-Name, Ultra-High-Yield Dividend Stocks Patient Investors Can Confidently Buy With $300 Right Now
05:06am, Thursday, 13'th Feb 2025
With thousands of publicly traded companies and exchange-traded funds (ETFs) to choose from, Wall Street offers no shortage of ways for investors to grow their wealth. But among this vast sea of pathw
U.S. FDA Approves Pfizer's ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
12:15pm, Wednesday, 12'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (b
Pfizer: 3 Key Risks That Warrant A Sell
06:04am, Wednesday, 12'th Feb 2025
Pfizer's business is facing material revenue shrink issues due to many patent expirations over the next 3 years. Quarterly revenue run rate analysis suggests management may be underestimating the impa
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Tuesday, 11'th Feb 2025
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the
A Historic Opportunity To Win Big With Dividend Stocks
03:28pm, Monday, 10'th Feb 2025
The current market offers a historic opportunity for dividend stocks. We detail why this is a historic opportunity for dividend investors. We also discuss some of the names that we are buying to take
Should Pfizer Stock Be in Your Portfolio Post a Robust Q4 Performance?
10:15am, Monday, 10'th Feb 2025
Investors may stay invested in PFE stock to see how its new growth drivers perform.
Pfizer: Challenges Loom Amid Overvaluation
09:39am, Monday, 10'th Feb 2025
I have downgraded Pfizer Inc. stock to Strong Sell due to stagnant revenue, substantial patent cliffs, regulatory, legal, and reputational headwinds, and overvaluation concerns. Despite a 24.7% YoY re
Better High-Yield Dividend Stock: Pfizer vs. Merck
04:29am, Monday, 10'th Feb 2025
Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical industry. At recent prices, you can buy shares of Merck (MRK -0.88%) that of
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
04:20am, Monday, 10'th Feb 2025
Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative biotech that may launch game-changing products down the road.
Fighting Cancer Becomes Top Priority for Pfizer
10:06am, Sunday, 09'th Feb 2025
Pfizer chairman and CEO Albert Bourla sees cancer as Pfizer's next big chance to save the world. The complexity of cancers makes treatments expensive to develop and challenging to customize, but the a
Is Now a Good Time to Buy the Dip on Pfizer?
06:02am, Sunday, 09'th Feb 2025
The past three years have been difficult for Pfizer (PFE -0.35%). The pharmaceutical giant's financial results worsened substantially as its coronavirus-related tailwind came to a screeching halt.
3 Dividend Stocks to Double Up on Right Now
05:43am, Sunday, 09'th Feb 2025
What's better than a good thing? More of a good thing.
Income Strategy: I'm Stashing Cash Into These Wonderful Dividends
08:00am, Saturday, 08'th Feb 2025
Inflation can be countered by investing in income-generating assets like consumer staples, energy, and pharmaceuticals, which provide essential products and reliable dividends. In this article, I high
